2023 Was a tricky calendar year with the biopharma field, with numerous companies downsizing and restructuring their workforces to remain afloat. There are actually signs of Restoration, as mergers and acquisitions picked up over the pharmaceutical and daily life sciences sector inside the latter Portion of 2023 and possess ongoing https://sites.google.com/view/bio-sites/blog